Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Antiphospholipid Syndrome (Phase 2)
Arthritis, Rheumatoid (Phase 3)
Glomerulonephritis, IGA (Phase 2)
Healthy Volunteers (Phase 1)
Lupus Erythematosus, Systemic (Phase 3)
Multiple Sclerosis, Relapsing-Remitting (Phase 2)
Myasthenia Gravis (Phase 2)
Neuromyelitis Optica (Phase 3)
Sjogren's Syndrome (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue